Related Experiment Video
Updated: Jul 17, 2026

Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
Published on: May 4, 2022
Clinical characteristics of a second small nodule(s) associated with cT1-2N0M0 non-small-cell lung cancer
Ho Il Yoon1, Jae-Jun Yim, Choon-Taek Lee
1Department of Internal Medicine, Seoul National University Bundang Hospital, Geonggi-do, Seongnam-si, 463-707, Republic of Korea. dextro@snubh.org
Abstract:
When a patient with cT(1-2)N(0)M(0) stage non-small-cell lung cancer (NSCLC) has a second small nodule(s), the treatment plan and prognosis depend largely on whether the nodule is benign or malignant. However, the incidence of malignancy of nodules associated with N(0) and M(0) NSCLC is unknown. Furthermore, predictive factors of malignancy have not been defined. Thus, we evaluated the nature of nodules that were less than 15 mm in diameter associated with stage T(1-2)N(0)M(0), and tried to identify clinical and radiologic factors predictive of malignancy. The study population consisted of 39 patients with T(1-2)N(0)M(0) NSCLC and a second nodule(s) less than 1.5 cm and who had received curative resection. Medical records and radiologic findings, including CT scans of the chest, were retrospectively reviewed. Nodules were finally diagnosed as benign in 85% and malignant in 15%. No significant differences in terms of gender, age, preoperative carcinoembryonic antigen (CEA) level, cell type, pathologic stages, shape, size, location and number of nodules, or the presence of calcification around nodules was observed between benign and malignant groups. We suggest that if primary NSCLC is resectable, an effort should be made to confirm the pathologic diagnosis of nodules. If histologic findings in nodules are not available, surgical resection should be actively considered, especially when nodules < 1.5 cm are associated with N(0) or M(0) NSCLCs.
Insights
For early-stage non-small-cell lung cancer (NSCLC) with small nodules, 15% are malignant. Predictive factors were not identified, suggesting surgical resection for nodules under 1.5 cm if the primary tumor is resectable.
Area of Science:
- Oncology
- Thoracic Surgery
- Radiology
Background:
- Distinguishing benign from malignant nodules is crucial for treatment planning in early-stage non-small-cell lung cancer (NSCLC).
- The incidence and predictive factors for malignancy in small nodules associated with stage T(1-2)N(0)M(0) NSCLC remain largely unknown.
Purpose of the Study:
- To evaluate the nature of small nodules (<15 mm) in patients with stage T(1-2)N(0)M(0) NSCLC.
- To identify clinical and radiologic factors predictive of malignancy in these nodules.
Main Methods:
- Retrospective review of medical records and chest CT scans from 39 patients with T(1-2)N(0)M(0) NSCLC and a second nodule (<1.5 cm) who underwent curative resection.
- Analysis of nodule characteristics, patient demographics, and preoperative tumor markers.
Main Results:
- Nodules were benign in 85% and malignant in 15% of cases.
- No significant differences were found between benign and malignant groups regarding gender, age, CEA levels, cell type, stage, nodule shape, size, location, number, or calcification.
Conclusions:
- Surgical resection should be considered for nodules <1.5 cm associated with N(0) or M(0) NSCLC, especially when histologic confirmation is unavailable.
- Confirming the pathologic diagnosis of nodules is recommended when the primary NSCLC is resectable.